These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8923333)

  • 1. Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteers.
    Thompson GA; St Peter JV; Heise MA; Horowitz ZD; Salyers GC; Charles TT; Brezovic C; Russell DA; Skare JA; Powell JH
    J Pharm Sci; 1996 Nov; 85(11):1242-7. PubMed ID: 8923333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
    Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
    Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy.
    Koren G; Vranderick M; Gill SK; Macleod S
    J Clin Pharmacol; 2013 Dec; 53(12):1268-76. PubMed ID: 24123059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxylamine pharmacokinetics following single dose oral administration in children ages 2-17 years.
    Balan G; Thompson GA; Gibb R; Li L; Hull D; Seeck M
    J Clin Pharmacol; 2013 Nov; 53(11):1177-85. PubMed ID: 23868556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of doxylamine, a component of Bendectin, in the rhesus monkey.
    Slikker W; Holder CL; Lipe GW; Bailey JR; Young JF
    Reprod Toxicol; 1989; 3(3):187-96. PubMed ID: 2520522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man.
    Ohnhaus EE; Breckenridge AM; Park BK
    Eur J Clin Pharmacol; 1989; 36(1):39-46. PubMed ID: 2917586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women.
    Friedman H; Greenblatt DJ; Scavone JM; Burstein ES; Ochs HR; Harmatz JS; Shader RI
    Clin Pharmacokinet; 1989 May; 16(5):312-6. PubMed ID: 2743704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative.
    Vital Durand D; Hampden C; Boobis AR; Park BK; Davies DS
    Br J Clin Pharmacol; 1986 Jan; 21(1):1-7. PubMed ID: 3947503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
    Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of doxylamine succinate on thyroid hormone balance and enzyme induction in mice.
    Bookstaff RC; Murphy VA; Skare JA; Minnema D; Sanzgiri U; Parkinson A
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):584-94. PubMed ID: 8975784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
    Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
    Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of doxylamine succinate in Fischer 344 rats. Part III: Conjugated urinary and fecal metabolites.
    Holder CL; Siitonen PH; Slikker W; Branscomb CJ; Korfmacher WA; Thompson HC; Cerniglia CE; Gosnell AB; Lay JO
    J Anal Toxicol; 1990; 14(4):247-51. PubMed ID: 1975634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy.
    Matok I; Clark S; Caritis S; Miodovnik M; Umans J; Hankins G; Koren G
    J Clin Pharmacol; 2013 Mar; 53(3):334-8. PubMed ID: 23444286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic bioavailability and pharmacokinetics of the doxylamine-pyridoxine delayed-release combination (Diclectin).
    Gill SK; Garcia-Bournissen F; Koren G
    Ther Drug Monit; 2011 Feb; 33(1):115-9. PubMed ID: 21079545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(5):185-94. PubMed ID: 8738854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial.
    Koren G; Clark S; Hankins GD; Caritis SN; Miodovnik M; Umans JG; Mattison DR
    Am J Obstet Gynecol; 2010 Dec; 203(6):571.e1-7. PubMed ID: 20843504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel and drug metabolism: absence of effect on hepatic enzymes in healthy volunteers.
    Pierce CH; Houle JM; Dickinson JP; Kindermans M; Serre-Lacroix E; Kieffer G; Necciari J
    Semin Thromb Hemost; 1999; 25 Suppl 2():35-9. PubMed ID: 10440421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urinary 6 beta-hydroxycortisol excretion in man on inducers and inhibitors of the hepatic mixed function oxidase.
    Desager JP; Dumont E; Harvengt C
    Pharmacol Ther; 1987; 33(1):197-9. PubMed ID: 3628474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.